News
Former Weill Cornell Medicine Dean Allegedly Faked Data for Two Decades — Now PETA Is Going After Him
|
Former Weill Cornell Medicine dean Dr. Augustine M.K. Choi allegedly manipulated data in research on animals.
Science
New Collaborative Cornell Research Finds SARS-CoV-2 can Infect and Deteriorate Dopamine Neurons
|
Weill Cornell researchers discover new insight into the effects of SARS-CoV-2 on the brain.
Science
Cornell Researchers Determine Amyloid Beta Interactions Associated with Alzheimer’s Disease and Cerebral Amyloid Angiopathy
|
Weill Cornell Medicine researchers gave new insights on the onset of Alzheimer’s disease and a cerebrovascular disorder known as cerebral amyloid angiopathy, identifying the mechanisms of the protein amyloid beta in an Oct. 3 study.
Science
Weill Cornell Researchers Discover Beta Cell Type Associated with Type 2 Diabetes
|
On March 16, Prof. James Lo, pharmacology cell and developmental biology, and his team published a study identifying different types of cells in the pancreas, an organ responsible for aiding digestion and regulating sugar levels. The research team found one particular cell type to be closely linked to the development of type 2 diabetes.
News
Profs. Craig Altier, Kyu Rhee Join Forces to Lead New Antimicrobial Resistance Center
|
Prof. Craig Altier and Prof. Kyu Rhee are collaborating to co-direct the new Center for Antimicrobial Resistance Research and Education, with the aim of better understanding and improving treatments for microbes resistant to existing medications.
Science
Disruptions in Circadian Clock Contributes to Fat Cell Growth, New Studies Find
|
Two recent studies conducted at Weill Cornell suggest that there’s more to gaining weight than diet. Chronic stress and disruptions in one’s circadian clocks may play a key role in fat cell growth.
Featured in Category
Weill Cornell Prof. to Study Relationship Between Sleep, Cardiovascular Disease and HIV in Tanzania
|
The National Institutes of Health recently awarded Dr. Robert Peck, associate professor of medicine in pediatrics at Weill Cornell, a grant to conduct the first longitudinal study on the relationship between sleep, cardiovascular disease and HIV in Tanzania.
community impact
Overcrowded Hospitals: How Weill’s Epidemic Modeling Tool Tackles Coronavirus Surge
|
In the fight against COVID-19, Weill Cornell’s Dr. Nathaniel Hupert has developed an epidemic modeling tool to help hospitals predict incoming patient rates.
Science
Cornell Research Group Explores Potential of Machine Learning in Medicine
|
Medicine and artificial intelligence are ever-evolving fields at the forefront of scientific discovery. A new Cornell research group — Machine Learning in Medicine — aims to coalesce the two, with the goal of improving methods for disease detection and diagnosis. This endeavor is a collaboration between faculty at Cornell Tech and Weill Cornell Medicine, bringing together “researchers with common interests and complementary expertise.” MLIM’s work is primarily an interdisciplinary dialogue, bridging campuses and research fields.
“The idea was to link people with a machine learning background in Ithaca to [people working with] clinical data and hypotheses at Weill,” said Prof. Amy Kuceyeski, mathematics and radiology, one of the organizing members of the group. While Kuceyeski’s background is in mathematics, she started learning methods for modeling biological systems as a postdoctoral researcher at Weill. Seeing this as an area for innovation, Kuceyeski helped establish MLIM in 2018.
Science
Targeting Ticks: Cornell-Housed Company Designs New Lyme Disease Test
|
Dr. Joel Tabb and team at Ionica Sciences at Weill Cornell has developed a new and improved diagnostic test for Lyme disease. Unlike the current standard tests, that focus on the body’s immune response, Tabb’s test focuses on the disease causing bacteria itself and should be on the market by 2020.